US Stock MarketDetailed Quotes
IBRX ImmunityBio
- 5.035
- 0.0000.00%
Close Nov 21 16:00 ET
- 5.080
- +0.045+0.90%
Pre 09:26 ET
3.51BMarket Cap-5532P/E (TTM)
0.000High0.000Low0Volume0.000Open5.035Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)696.83MShares10.53052wk High-4.71P/B834.64MFloat Cap3.10052wk Low--Dividend TTM165.77MShs Float45.420Historical High--Div YieldTTM0.00%Amplitude0.930Historical Low--Avg Price1Lot Size
ImmunityBio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7,346.34%6.11M | 2,453.66%1.05M | -88.89%40K | 159.17%622K | 90.41%139K | -30.51%82K | 17.14%41K | 2,471.43%360K | -74.30%240K | -81.28%73K |
| Operating revenue | --5.95M | --990K | -88.89%40K | 159.17%622K | 752.05%622K | --0 | --0 | 2,471.43%360K | -74.30%240K | -81.28%73K |
| Cost of revenue | 0 | 0 | 0 | 0 | ||||||
| Gross profit | 7,346.34%6.11M | 2,453.66%1.05M | 82K | 41K | ||||||
| Operating expense | 7.66%86.36M | 17.84%100.38M | -14.92%95.24M | 3.17%361.99M | 0.42%84.64M | -11.77%80.22M | 6.94%85.19M | 16.62%111.94M | 5.93%350.86M | 5.81%84.29M |
| Selling and administrative expenses | 12.89%35.92M | 53.82%49.25M | 28.18%41.89M | 26.20%129.62M | 26.30%33.11M | 64.76%31.82M | 93.17%32.02M | -19.53%32.68M | -24.06%102.71M | -6.08%26.22M |
| Research and development costs | 4.22%50.44M | -3.84%51.13M | -32.69%53.35M | -6.36%232.37M | -11.27%51.53M | -32.41%48.4M | -15.72%53.17M | 43.13%79.26M | 26.63%248.15M | 12.22%58.08M |
| Operating profit | -0.15%-80.25M | -16.66%-99.33M | 14.68%-95.2M | -3.07%-361.36M | -0.34%-84.5M | 11.75%-80.14M | -6.94%-85.15M | -16.26%-111.58M | -6.16%-350.62M | -6.24%-84.22M |
| Net non-operating interest income expense | -15.11%-39.61M | -20.68%-38.19M | -26.40%-37.33M | -111.05%-128.34M | -16.76%-32.75M | -108.41%-34.41M | -249.49%-31.64M | -310.45%-29.53M | -333.93%-60.81M | -566.83%-28.05M |
| Non-operating interest income | 4.59%638K | 40.71%833K | -43.66%160K | -68.13%863K | -220.97%-623K | 141.11%610K | -8.07%592K | -78.09%284K | 223.92%2.71M | 81.34%515K |
| Non-operating interest expense | 14.92%40.25M | 21.05%39.02M | 25.73%37.49M | 103.41%129.2M | 12.48%32.13M | 108.91%35.02M | 232.39%32.24M | 251.98%29.82M | 327.74%63.52M | 536.12%28.56M |
| Other net income (expense) | 80.43%34.11M | 113.70%2.94M | -106.55%-1.61M | -1,506.84%-94.19M | -3,024.06%-116.2M | 591.55%18.91M | -247.86%-21.43M | 14,414.20%24.53M | -5.70%-5.86M | 149.23%3.97M |
| Gain on sale of security | 149.07%34.1M | 127.66%2.95M | -105.68%-1.59M | -717.75%-47.33M | -957.35%-78.29M | 2,166.56%13.69M | -336.66%-10.67M | 7,452.16%27.94M | 255.23%7.66M | 226.66%9.13M |
| Earnings from equity interest | --0 | --0 | --0 | 37.65%-7.55M | --0 | 71.84%-1.26M | -1.46%-3.96M | -1,086.29%-2.34M | -1,407.72%-12.11M | -342.59%-3.55M |
| Special income (charges) | ---- | ---- | ---- | -30.10%-886K | ---- | ---- | ---- | ---- | ---681K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 30.10%886K | ---- | ---- | ---- | ---- | --681K | ---- |
| Other non- operating income (expenses) | -99.81%12K | 99.75%-17K | 98.14%-20K | -5,120.92%-38.43M | -3,911.16%-37.02M | 107,733.33%6.47M | -3,773.51%-6.8M | -26,825.00%-1.08M | -481.35%-736K | -1,464.41%-923K |
| Income before tax | 10.34%-85.75M | 2.63%-134.58M | -15.05%-134.13M | -39.93%-583.89M | -115.58%-233.45M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M | -19.28%-417.29M | -18.28%-108.29M |
| Income tax | 0 | 0 | 0 | -217.65%-40K | -217.65%-40K | 0 | 0 | 0 | 277.78%34K | 3,300.00%34K |
| Net income | 10.34%-85.75M | 2.63%-134.58M | -15.05%-134.13M | -39.91%-583.85M | -115.47%-233.41M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M | -19.29%-417.32M | -18.32%-108.33M |
| Net income continuous Operations | 10.34%-85.75M | 2.63%-134.58M | -15.05%-134.13M | -39.91%-583.85M | -115.47%-233.41M | 13.96%-95.64M | -45.74%-138.21M | -13.19%-116.58M | -19.29%-417.32M | -18.32%-108.33M |
| Minority interest income | 61.67%-23K | 94.01%-20K | 91.25%-21K | 12.88%-656K | 80.18%-22K | 73.09%-60K | -35.22%-334K | -39.53%-240K | 75.38%-753K | 62.24%-111K |
| Net income attributable to the parent company | 10.31%-85.73M | 2.40%-134.56M | -15.27%-134.11M | -40.00%-583.2M | -115.67%-233.39M | 13.84%-95.58M | -45.77%-137.88M | -13.15%-116.34M | -20.12%-416.57M | -18.58%-108.22M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 10.31%-85.73M | 2.40%-134.56M | -15.27%-134.11M | -40.00%-583.2M | -115.67%-233.39M | 13.84%-95.58M | -45.77%-137.88M | -13.15%-116.34M | -20.12%-416.57M | -18.58%-108.22M |
| Basic earnings per share | 36.84%-0.12 | 37.50%-0.2 | 25.93%-0.2 | -10.58%-1.15 | -40.74%-0.38 | 32.14%-0.19 | -33.33%-0.32 | -3.85%-0.27 | -16.85%-1.04 | -17.39%-0.27 |
| Diluted earnings per share | 36.84%-0.12 | 37.50%-0.2 | 25.93%-0.2 | -10.58%-1.15 | -40.74%-0.38 | 32.14%-0.19 | -33.33%-0.32 | -3.85%-0.27 | -16.85%-1.04 | -17.39%-0.27 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data